Jorge DiMartino insider trades: Kronos Bio (KRON) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jorge reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | KRON | ↓ Sell | 12,009 | $1.18 | $14K | Direct | Jan 5, 2024 (1d) |
| Dec 12, 2023 | KRON | ↓ Sell | 17,367 | $1.30 | $23K | Direct | Dec 13, 2023 (1d) |
| Jul 6, 2023 | KRON | ↓ Sell | 10,818 | $1.75 | $19K | Direct | Jul 7, 2023 (1d) |
| Feb 24, 2023 | KRON | ↓ Sell | 10,153 | $1.74 | $18K | Direct | Feb 24, 2023 (0d) |
| Dec 12, 2022 | KRON | ↓ Sell | 18,657 | $1.81 | $34K | Direct | Dec 14, 2022 (2d) |
| Dec 13, 2021 | KRON | ↓ Sell | 16,402 | $12.37 | $203K | Direct | Dec 15, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jorge DiMartino's insider trades
Jorge DiMartino is Chief Medical Officer & VP at Kronos Bio (KRON). Since Dec 13, 2021, Jorge has reported no open-market purchases and 6 sales worth $310K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KRON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.